Home LiteratureArticle Details
PMID: 24505328 Published · epublish English Clinical Trial Journal Article Research Support, N.I.H., Extramural

Supporting a role for the GTPase Rab7 in prostate cancer progression.

PloS one ·Vol. 9 ·No. 2 ·2014-00-00 ·Pages e87882

Steffan JJ, Dykes SS, Coleman DT, Adams LK, Rogers D, Carroll JL, Williams BJ, Cardelli JA

Abstract

Invasion and subsequent metastasis is the major cause of death from most cancers including prostate cancer. Herein we report on the potential tumor suppressive properties of Rab7, a GTPase that regulates trafficking of lysosomes. The movement of lysosomes to the cell surface in response to environmental cues increases the secretion of proteinases and cell invasion. We determined that Troglitazone and other members of the Thiazolidinedione family inhibit cell-surface directed lysosome trafficking and cathepsin B secretion through a Rab7-dependent mechanism. Moreover, Rab7 shRNA expressing cells were found to be more invasive in vitro and in vivo. Increased invasiveness was accompanied by elevated expression of the c-Met receptor and prolonged downstream signaling, thereby supporting a role for Rab7 as a mediator of signaling down-regulation. Taken together, these results suggested that Rab7 acts as a negative regulator of prostate tumor growth and invasion, providing further evidence for its potential as a tumor suppressor.

MeSH Terms
Animals Cell Line, Tumor Gene Expression Regulation, Enzymologic Gene Expression Regulation, Neoplastic Humans Hypoglycemic Agents/pharmacology Male Mice, SCID Neoplasm Invasiveness Prostatic Neoplasms/enzymology,pathology Thiazolidinediones Tumor Suppressor Proteins/biosynthesis rab GTP-Binding Proteins/biosynthesis rab7 GTP-Binding Proteins
Chemicals
Hypoglycemic Agents Thiazolidinediones Tumor Suppressor Proteins rab7 GTP-Binding Proteins rab7 GTP-binding proteins, human rab7 GTP-binding proteins, mouse 2,4-thiazolidinedione rab GTP-Binding Proteins
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Steffan Joshua J
Department of Microbiology and Immunology, Louisiana State University Health Sciences Center, Shreveport, Louisiana, United States of America ; Feist-Weiller Cancer Center, Louisiana State University Health Sciences Center, Shreveport, Louisiana, United States of America ; Department of Natural Science, Dickinson State University, Dickinson, North Dakota, United States of America.
Dykes Samantha S
Department of Microbiology and Immunology, Louisiana State University Health Sciences Center, Shreveport, Louisiana, United States of America ; Feist-Weiller Cancer Center, Louisiana State University Health Sciences Center, Shreveport, Louisiana, United States of America.
Coleman David T
Department of Microbiology and Immunology, Louisiana State University Health Sciences Center, Shreveport, Louisiana, United States of America ; Feist-Weiller Cancer Center, Louisiana State University Health Sciences Center, Shreveport, Louisiana, United States of America.
Adams Lisa K
Feist-Weiller Cancer Center, Louisiana State University Health Sciences Center, Shreveport, Louisiana, United States of America ; Department of Biochemistry and Molecular Biology, Louisiana State University Health Sciences Center, Shreveport, Louisiana, United States of America.
Rogers Donna
Feist-Weiller Cancer Center, Louisiana State University Health Sciences Center, Shreveport, Louisiana, United States of America ; Department of Biochemistry and Molecular Biology, Louisiana State University Health Sciences Center, Shreveport, Louisiana, United States of America.
Carroll Jennifer L
Feist-Weiller Cancer Center, Louisiana State University Health Sciences Center, Shreveport, Louisiana, United States of America ; Department of Biochemistry and Molecular Biology, Louisiana State University Health Sciences Center, Shreveport, Louisiana, United States of America.
Williams B Jill
Feist-Weiller Cancer Center, Louisiana State University Health Sciences Center, Shreveport, Louisiana, United States of America ; Department of Biochemistry and Molecular Biology, Louisiana State University Health Sciences Center, Shreveport, Louisiana, United States of America ; Department of Urology, Louisiana State University Health Sciences Center, Shreveport, Louisiana, United States of America.
Cardelli James A
Department of Microbiology and Immunology, Louisiana State University Health Sciences Center, Shreveport, Louisiana, United States of America ; Feist-Weiller Cancer Center, Louisiana State University Health Sciences Center, Shreveport, Louisiana, United States of America.
References (45)
45 references, click to expand
  1. Cathepsin B and tumor proteolysis: contribution of the tumor microenvironment.
    Semin Cancer Biol. 2005 Apr;15(2):149-57 PMID: 15652460
  2. Peroxisome proliferator-activated receptor modulators as potential chemopreventive agents.
    Mol Cancer Ther. 2002 Mar;1(5):357-63 PMID: 12489852
  3. Rab7: roles in membrane trafficking and disease.
    Biosci Rep. 2009 Jun;29(3):193-209 PMID: 19392663
  4. Gene expression profiling identifies clinically relevant subtypes of prostate cancer.
    Proc Natl Acad Sci U S A. 2004 Jan 20;101(3):811-6 PMID: 14711987
  5. Actin filaments and myosin I alpha cooperate with microtubules for the movement of lysosomes.
    Mol Biol Cell. 2001 Dec;12(12):4013-29 PMID: 11739797
  6. Sex-determining region Y box 4 is a transforming oncogene in human prostate cancer cells.
    Cancer Res. 2006 Apr 15;66(8):4011-9 PMID: 16618720
  7. A microenvironmental model of carcinogenesis.
    Nat Rev Cancer. 2008 Jan;8(1):56-61 PMID: 18059462
  8. HGF-induced invasion by prostate tumor cells requires anterograde lysosome trafficking and activity of Na+-H+ exchangers.
    J Cell Sci. 2010 Apr 1;123(Pt 7):1151-9 PMID: 20215403
  9. PPARgamma-independent antitumor effects of thiazolidinediones.
    Cancer Lett. 2009 Apr 18;276(2):119-24 PMID: 18790559
  10. Malignant transformation alters intracellular trafficking of lysosomal cathepsin D in human breast epithelial cells.
    Pathol Oncol Res. 1998;4(4):283-96 PMID: 9887359
  11. Unraveling the role of proteases in cancer.
    Clin Chim Acta. 2000 Feb 15;291(2):113-35 PMID: 10675719
  12. The endocytic catalysts, Rab5a and Rab7, are tandem regulators of thyroid hormone production.
    Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):8277-82 PMID: 12034881
  13. Growth factors regulate cell survival by controlling nutrient transporter expression.
    Biochem Soc Trans. 2005 Feb;33(Pt 1):225-7 PMID: 15667313
  14. EMT, the cytoskeleton, and cancer cell invasion.
    Cancer Metastasis Rev. 2009 Jun;28(1-2):15-33 PMID: 19169796
  15. Thiazolidinediones induce Rab7-RILP-MAPK-dependent juxtanuclear lysosome aggregation and reduce tumor cell invasion.
    Traffic. 2010 Feb;11(2):274-86 PMID: 20015112
  16. Rab7 prevents growth factor-independent survival by inhibiting cell-autonomous nutrient transporter expression.
    Dev Cell. 2003 Oct;5(4):571-82 PMID: 14536059
  17. Na+/H+ exchangers and RhoA regulate acidic extracellular pH-induced lysosome trafficking in prostate cancer cells.
    Traffic. 2009 Jun;10(6):737-53 PMID: 19302267
  18. Integrative molecular concept modeling of prostate cancer progression.
    Nat Genet. 2007 Jan;39(1):41-51 PMID: 17173048
  19. Tumor immunobiological differences in prostate cancer between African-American and European-American men.
    Cancer Res. 2008 Feb 1;68(3):927-36 PMID: 18245496
  20. Gene expression signatures differentiate ovarian/peritoneal serous carcinoma from diffuse malignant peritoneal mesothelioma.
    Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):5944-50 PMID: 17062665
  21. Acid treatment of melanoma cells selects for invasive phenotypes.
    Clin Exp Metastasis. 2008;25(4):411-25 PMID: 18301995
  22. Rab7 and Rab27a control two motor protein activities involved in melanosomal transport.
    Pigment Cell Res. 2006 Oct;19(5):412-23 PMID: 16965270
  23. Tumour-cell invasion and migration: diversity and escape mechanisms.
    Nat Rev Cancer. 2003 May;3(5):362-74 PMID: 12724734
  24. Rab7 mutants associated with Charcot-Marie-Tooth disease exhibit enhanced NGF-stimulated signaling.
    PLoS One. 2010 Dec 09;5(12):e15351 PMID: 21151572
  25. Rab7 mutants associated with Charcot-Marie-Tooth disease cause delayed growth factor receptor transport and altered endosomal and nuclear signaling.
    J Biol Chem. 2013 Jan 11;288(2):1135-49 PMID: 23188822
  26. Involvement of Rabring7 in EGF receptor degradation as an E3 ligase.
    Biochem Biophys Res Commun. 2007 Jun 15;357(4):1058-64 PMID: 17462600
  27. Pericellular pH affects distribution and secretion of cathepsin B in malignant cells.
    Cancer Res. 1994 Dec 15;54(24):6517-25 PMID: 7987851
  28. The small GTPase Rab7 controls the endosomal trafficking and neuritogenic signaling of the nerve growth factor receptor TrkA.
    J Neurosci. 2005 Nov 23;25(47):10930-40 PMID: 16306406
  29. Pericellular cathepsin B and malignant progression.
    Cancer Metastasis Rev. 2003 Jun-Sep;22(2-3):271-86 PMID: 12785001
  30. Transcriptional silencing of zinc finger protein 185 identified by expression profiling is associated with prostate cancer progression.
    Cancer Res. 2003 Jul 15;63(14):3877-82 PMID: 12873976
  31. Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression.
    Cancer Cell. 2005 Nov;8(5):393-406 PMID: 16286247
  32. Rab7 activation by growth factor withdrawal contributes to the induction of apoptosis.
    Mol Biol Cell. 2009 Jun;20(12):2831-40 PMID: 19386765
  33. Derailed endocytosis: an emerging feature of cancer.
    Nat Rev Cancer. 2008 Nov;8(11):835-50 PMID: 18948996
  34. RAB-7 antagonizes LET-23 EGFR signaling during vulva development in Caenorhabditis elegans.
    PLoS One. 2012;7(4):e36489 PMID: 22558469
  35. The Rab7 effector protein RILP controls lysosomal transport by inducing the recruitment of dynein-dynactin motors.
    Curr Biol. 2001 Oct 30;11(21):1680-5 PMID: 11696325
  36. Tube travel: the role of proteases in individual and collective cancer cell invasion.
    Cancer Res. 2008 Sep 15;68(18):7247-9 PMID: 18794108
  37. RILP is required for the proper morphology and function of late endosomes.
    J Cell Sci. 2007 Nov 1;120(Pt 21):3729-37 PMID: 17959629
  38. Extracellular acidification alters lysosomal trafficking in human breast cancer cells.
    Neoplasia. 2003 Nov-Dec;5(6):533-45 PMID: 14965446
  39. rab7 activity affects epidermal growth factor:epidermal growth factor receptor degradation by regulating endocytic trafficking from the late endosome.
    J Biol Chem. 2006 Jan 13;281(2):1099-106 PMID: 16282324
  40. Beyond peroxisome proliferator-activated receptor gamma signaling: the multi-facets of the antitumor effect of thiazolidinediones.
    Endocr Relat Cancer. 2006 Jun;13(2):401-13 PMID: 16728570
  41. Cathepsin B to cysteine proteinase inhibitor balance in metastatic cell subpopulations isolated from murine tumors.
    Cancer Res. 1990 Oct 1;50(19):6278-84 PMID: 2400991
  42. Cathepsin B expression and localization in glioma progression and invasion.
    Cancer Res. 1994 Dec 1;54(23):6027-31 PMID: 7954439
  43. The Arf-family protein, Arl8b, is involved in the spatial distribution of lysosomes.
    Biochem Biophys Res Commun. 2006 Jun 16;344(4):1186-91 PMID: 16650381
  44. Targeting vesicle trafficking: an important approach to cancer chemotherapy.
    Recent Pat Anticancer Drug Discov. 2008 Jun;3(2):137-47 PMID: 18537756
  45. The MET receptor tyrosine kinase in invasion and metastasis.
    J Cell Physiol. 2007 Nov;213(2):316-25 PMID: 17607709
Article Info
Journal
PloS one
Abbr.
PLoS One
ISSN
1932-6203
Published
2014-00-00
Epub
2014-00-05
Pages
e87882
Language
English
Region
United States
NLM ID
101285081
PMCID
PMC3914878
Subset
IM
Grants
NCI NIH HHS · R01 CA104242 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com